JPRN-UMIN000031978已完成未知
TECENTRIQ Drug Use Surveillance(advanced or recurrent non-small cell lung cancer) - TECENTRIQ Drug Use Surveillance(NSCLC)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No criteria
研究者
相似试验
招募中
不适用
A Survey of Brentuximab Vedotin in Pediatric Participants with Hodgkin LymphomaHodgkin LymphomaJPRN-jRCT2031220244Contact for Clinical Trial Information8
招募中
不适用
General Drug Use Surveillance (All Patient Surveillance) of ENSPRYNG Syringes for Subcutaneous Injection - Prevention of relapses of neuromyelitis optica spectrum disorder (including neuromyelitis optica)JPRN-UMIN000041047Chugai Pharmaceutical Co. Ltd.330
已完成
不适用
Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg TabletsAttention deficit hyperactivity disorder (ADHD)JPRN-UMIN000015900Janssen Pharmaceutical K.K500
已完成
不适用
Special Drug Use-results Surveillance for long term administration of XEPLION (Paliperidone Palmitate 1 month formulation), 25mg/ 50mg/ 75mg/ 100mg/ 150mg syringeSchizophreniaJPRN-UMIN000018665Janssen Pharmaceutical K.K.1,050
已完成
不适用
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion Relapsed or refractory CD30-positive peripheral T cell lymphoma or Pediatric Hodgkin LymphomaPeripheral T cell lymphoma and Pediatric Hodgkin lymphomaJPRN-jRCT1080224999Takeda Pharmaceutical Company Limited95